Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer
Clinical trial NCT00329940 · COMPLETED
Trial details
- NCT number
- NCT00329940
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2008-01-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.